Articles with public access mandates - Leonie YoungLearn more
Not available anywhere: 3
Genomic interaction between ER and HMGB2 identifies DDX18 as a novel driver of endocrine resistance in breast cancer cells
AM Redmond, C Byrne, FT Bane, GD Brown, P Tibbitts, K O’Brien, ...
Oncogene 34 (29), 3871-3880, 2015
Mandates: Health Research Board, Ireland, Cancer Research UK, European Commission …
Growth factor receptor/steroid receptor cross talk in trastuzumab-treated breast cancer
DC Collins, S Cocchiglia, P Tibbitts, G Solon, FT Bane, J McBryan, ...
Oncogene 34 (4), 525-530, 2015
Mandates: Health Research Board, Ireland, Science Foundation Ireland
BET inhibition as a rational therapeutic strategy for invasive lobular breast cancer
L Walsh, KE Haley, B Moran, B Mooney, F Tarrant, SF Madden, ...
Clinical Cancer Research 25 (23), 7139-7150, 2019
Mandates: Science Foundation Ireland, Breast Cancer Now, UK, Cancer Research UK …
Available somewhere: 53
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer
SA Eccles, EO Aboagye, S Ali, AS Anderson, J Armes, F Berditchevski, ...
Breast Cancer Research 15, 1-37, 2013
Mandates: UK Biotechnology and Biological Sciences Research Council, Cancer Research …
The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expression
L Qin, L Liao, A Redmond, L Young, Y Yuan, H Chen, BW O'Malley, J Xu
Molecular and cellular biology 28 (19), 5937-5950, 2008
Mandates: US National Institutes of Health
Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases.
LAV Priedigkeit N, Hartmaier RJ, Chen Y, Vareslija D, Basudan A, Watters RJ ...
JAMA Oncology 3 (5), 666-671, 2017
Mandates: US National Institutes of Health, Susan G. Komen
The function of steroid receptor coactivator-1 in normal tissues and cancer
CA Walsh, L Qin, JCY Tien, LS Young, J Xu
International journal of biological sciences 8 (4), 470, 2012
Mandates: US National Institutes of Health, Science Foundation Ireland
CD44 increases the efficiency of distant metastasis of breast cancer
S McFarlane, JA Coulter, P Tibbits, A O'Grady, C McFarlane, ...
Oncotarget 6 (13), 11465, 2015
Mandates: Health Research Board, Ireland, Cancer Research UK, Prostate Cancer UK
Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancer.
OS Pathiraja TN1, Nayak SR, Xi Y, Jiang S, Garee JP, Edwards DP, Lee AV ...
Science Translational Medicine. 6 (229), 229ra41, 2014
Mandates: US National Institutes of Health
Coassociation of estrogen receptor and p160 proteins predicts resistance to endocrine treatment; SRC-1 is an independent predictor of breast cancer recurrence
AM Redmond, FT Bane, AT Stafford, M McIlroy, MF Dillon, TB Crotty, ...
Clinical Cancer Research 15 (6), 2098-2106, 2009
Mandates: Science Foundation Ireland
Transcriptome characterization of matched primary breast and brain metastatic tumors to detect novel actionable targets
D Varešlija, N Priedigkeit, A Fagan, S Purcell, N Cosgrove, PJ O’Halloran, ...
JNCI: Journal of the National Cancer Institute 111 (4), 388-398, 2019
Mandates: US National Institutes of Health, Science Foundation Ireland, Susan G. Komen
Metastatic progression with resistance to aromatase inhibitors is driven by the steroid receptor coactivator SRC-1
J McBryan, SM Theissen, C Byrne, E Hughes, S Cocchiglia, S Sande, ...
Cancer research 72 (2), 548-559, 2012
Mandates: Science Foundation Ireland
Interaction of developmental transcription factor HOXC11 with steroid receptor coactivator SRC-1 mediates resistance to endocrine therapy in breast cancer
M McIlroy, D McCartan, S Early, PO Gaora, S Pennington, ADK Hill, ...
Cancer research 70 (4), 1585-1594, 2010
Mandates: Science Foundation Ireland
Brain metastasis cell lines panel: a public resource of organotropic cell lines
M Valiente, AED Van Swearingen, CK Anders, A Bairoch, A Boire, PD Bos, ...
Cancer research 80 (20), 4314-4323, 2020
Mandates: US Department of Defense, US National Institutes of Health, Cancer Research …
NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis
L Qin, YL Wu, MJ Toneff, D Li, L Liao, X Gao, FT Bane, JCY Tien, Y Xu, ...
Cancer research 74 (13), 3477-3488, 2014
Mandates: US National Institutes of Health
Junctional adhesion molecule-A is co-expressed with HER2 in breast tumors and acts as a novel regulator of HER2 protein degradation and signaling
K Brennan, EA McSherry, L Hudson, EW Kay, ADK Hill, LS Young, ...
Oncogene 32 (22), 2799-2804, 2013
Mandates: Science Foundation Ireland
Global characterization of the SRC-1 transcriptome identifies ADAM22 as an ER-independent mediator of endocrine-resistant breast cancer
D McCartan, JC Bolger, A Fagan, C Byrne, Y Hao, L Qin, M McIlroy, J Xu, ...
Cancer research 72 (1), 220-229, 2012
Mandates: US National Institutes of Health, Science Foundation Ireland
Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities
N Cosgrove, D Varešlija, S Keelan, A Elangovan, JM Atkinson, ...
Nature communications 13 (1), 514, 2022
Mandates: US National Institutes of Health, Science Foundation Ireland, Breast Cancer …
AIB1: ERα Transcriptional Activity Is Selectively Enhanced in Aromatase Inhibitor–Resistant Breast Cancer Cells
J O'Hara, D Vareslija, J McBryan, F Bane, P Tibbitts, C Byrne, RM Conroy, ...
Clinical Cancer Research 18 (12), 3305-3315, 2012
Mandates: Science Foundation Ireland
Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism
C Monteiro, L Miarka, M Perea-García, N Priego, P Garcia-Gomez, ...
Nature medicine 28 (4), 752-765, 2022
Mandates: US National Institutes of Health, European Molecular Biology Laboratory …
Publication and funding information is determined automatically by a computer program